Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

1.

Metabolic roles of PGC-1α and its implications for type 2 diabetes.

Besseiche A, Riveline JP, Gautier JF, Bréant B, Blondeau B.

Diabetes Metab. 2015 Mar 5. pii: S1262-3636(15)00026-9. doi: 10.1016/j.diabet.2015.02.002. [Epub ahead of print] Review.

PMID:
25753246
2.

Incretin-based therapy and pancreatic beta cells.

Chon S, Riveline JP, Blondeau B, Gautier JF.

Diabetes Metab. 2014 Dec;40(6):411-22.

PMID:
25443548
3.

Assessment of a new insulin preparation for implanted pumps used in the treatment of type 1 diabetes.

Schaepelynck P, Riveline JP, Renard E, Hanaire H, Guerci B, Baillot-Rudoni S, Sola-Gazagnes A, Catargi B, Fontaine P, Millot L, Martin JF, Tachouaft H, Jeandidier N; EVADIAC Group.

Diabetes Technol Ther. 2014 Sep;16(9):582-9. doi: 10.1089/dia.2013.0369. Epub 2014 Apr 15.

PMID:
24735100
4.

Fetal PGC-1α overexpression programs adult pancreatic β-cell dysfunction.

Valtat B, Riveline JP, Zhang P, Singh-Estivalet A, Armanet M, Venteclef N, Besseiche A, Kelly DP, Tronche F, Ferré P, Gautier JF, Bréant B, Blondeau B.

Diabetes. 2013 Apr;62(4):1206-16. doi: 10.2337/db12-0314. Epub 2012 Dec 28.

5.

Fear of hypoglycaemia in patients with type 1 diabetes: do patients and diabetologists feel the same way?

Böhme P, Bertin E, Cosson E, Chevalier N; GEODE group.

Diabetes Metab. 2013 Feb;39(1):63-70. doi: 10.1016/j.diabet.2012.10.006. Epub 2012 Dec 23.

6.

Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE.

Benhamou PY, Catargi B, Delenne B, Guerci B, Hanaire H, Jeandidier N, Leroy R, Meyer L, Penfornis A, Radermecker RP, Renard E, Baillot-Rudoni S, Riveline JP, Schaepelynck P, Sola-Gazagnes A, Sulmont V, Tubiana-Rufi N, Durain D, Mantovani I, Sola-Gazagnes A, Riveline JP; Société Francophone du Diabète; Société Française d'Endocrinologie; EVAluation dans le Diabète des Implants ACtifs Group.

Diabetes Metab. 2012 Jul;38 Suppl 4:S67-83. doi: 10.1016/S1262-3636(12)71538-0. No abstract available.

PMID:
22980520
7.

Renal complications correlate with electrical atrial vulnerability hallmarks in type 2 diabetic patients.

Montaigne D, Bailloeuil O, Hulin-Delmotte C, Edme JL, Sosner P, Miot A, Ragot S, Saulnier PJ, Dupuy O, Gourdy P, Lecomte P, Guerci B, Dardari D, Roussel R, Neviere R, Lacroix D, Hadjadj S; DIAB2NEPHROGENE and SURDIAGENE study groups.

Int J Cardiol. 2012 Aug 9;159(1):63-6. doi: 10.1016/j.ijcard.2012.04.035. Epub 2012 Jun 18. No abstract available.

PMID:
22713678
8.

Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study.

Riveline JP, Schaepelynck P, Chaillous L, Renard E, Sola-Gazagnes A, Penfornis A, Tubiana-Rufi N, Sulmont V, Catargi B, Lukas C, Radermecker RP, Thivolet C, Moreau F, Benhamou PY, Guerci B, Leguerrier AM, Millot L, Sachon C, Charpentier G, Hanaire H; EVADIAC Sensor Study Group.

Diabetes Care. 2012 May;35(5):965-71. doi: 10.2337/dc11-2021. Epub 2012 Mar 28.

9.

Clinical and metabolic features of adult-onset diabetes caused by ABCC8 mutations.

Riveline JP, Rousseau E, Reznik Y, Fetita S, Philippe J, Dechaume A, Hartemann A, Polak M, Petit C, Charpentier G, Gautier JF, Froguel P, Vaxillaire M.

Diabetes Care. 2012 Feb;35(2):248-51. doi: 10.2337/dc11-1469. Epub 2011 Dec 30.

10.

Is continuous glucose monitoring (CGM) for everyone? To whom should CGM be prescribed and how?

Riveline JP.

Diabetes Metab. 2011 Dec;37 Suppl 4:S80-4. doi: 10.1016/S1262-3636(11)70971-5. Review.

11.

Novel susceptibility locus at 22q11 for diabetic nephropathy in type 1 diabetes.

Wessman M, Forsblom C, Kaunisto MA, Söderlund J, Ilonen J, Sallinen R, Hiekkalinna T, Parkkonen M, Maxwell AP, Tarnow L, Parving HH, Hadjadj S, Marre M, Peltonen L, Groop PH; FinnDiane Study Group.

PLoS One. 2011;6(9):e24053. doi: 10.1371/journal.pone.0024053. Epub 2011 Sep 1.

12.

Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene.

Bellanné-Chantelot C, Lévy DJ, Carette C, Saint-Martin C, Riveline JP, Larger E, Valéro R, Gautier JF, Reznik Y, Sola A, Hartemann A, Laboureau-Soares S, Laloi-Michelin M, Lecomte P, Chaillous L, Dubois-Laforgue D, Timsit J; French Monogenic Diabetes Study Group.

J Clin Endocrinol Metab. 2011 Aug;96(8):E1346-51. doi: 10.1210/jc.2011-0268. Epub 2011 Jun 15.

PMID:
21677039
13.

A recent survey confirms the efficacy and the safety of implanted insulin pumps during long-term use in poorly controlled type 1 diabetes patients.

Schaepelynck P, Renard E, Jeandidier N, Hanaire H, Fermon C, Rudoni S, Catargi B, Riveline JP, Guerci B, Millot L, Martin JF, Sola A; EVADIAC Group.

Diabetes Technol Ther. 2011 Jun;13(6):657-60. doi: 10.1089/dia.2010.0209. Epub 2011 Apr 6.

PMID:
21470000
14.

Fetal exposure to maternal type 1 diabetes is associated with renal dysfunction at adult age.

Abi Khalil C, Travert F, Fetita S, Rouzet F, Porcher R, Riveline JP, Hadjadj S, Larger E, Roussel R, Vexiau P, Le Guludec D, Gautier JF, Marre M.

Diabetes. 2010 Oct;59(10):2631-6. doi: 10.2337/db10-0419. Epub 2010 Jul 9.

15.

Can postprandial blood glucose excursion be predicted in type 2 diabetes?

Franc S, Dardari D, Peschard C, Riveline JP, Biedzinski M, Boucherie B, Petit C, Requeda E, Mistretta F, Varroud-Vial M, Charpentier G.

Diabetes Care. 2010 Sep;33(9):1913-8. doi: 10.2337/dc10-0115. Epub 2010 Jun 14.

16.

Survival as a function of HbA(1c) in people with type 2 diabetes.

Riveline JP, Roussel R, Mohammedi K.

Lancet. 2010 Apr 24;375(9724):1433; author reply 1434-5. doi: 10.1016/S0140-6736(10)60612-5. No abstract available.

PMID:
20417850
17.

Sexual activity in diabetic patients treated by continuous subcutaneous insulin infusion therapy.

Riveline JP, Franc S, Biedzinski M, Jollois FX, Messaoudi N, Lagarde F, Lormeau B, Pichard S, Varroud-Vial M, Deburge A, Dresco E, Charpentier G; Groupe Pompe Sud-Francilien.

Diabetes Metab. 2010 Jun;36(3):229-33. doi: 10.1016/j.diabet.2010.01.004. Epub 2010 Mar 19.

18.

Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes: response to Kazempour-Ardebili et al.

Riveline JP, Hadjadj S.

Diabetes Care. 2009 Dec;32(12):e155; author reply e156. doi: 10.2337/dc09-1225. No abstract available.

PMID:
19940218
19.

Real-life application and validation of flexible intensive insulin-therapy algorithms in type 1 diabetes patients.

Franc S, Dardari D, Boucherie B, Riveline JP, Biedzinski M, Petit C, Requeda E, Leurent P, Varroud-Vial M, Hochberg G, Charpentier G.

Diabetes Metab. 2009 Dec;35(6):463-8. doi: 10.1016/j.diabet.2009.05.006. Epub .

20.

Genetic variant in HK1 is associated with a proanemic state and A1C but not other glycemic control-related traits.

Bonnefond A, Vaxillaire M, Labrune Y, Lecoeur C, Chèvre JC, Bouatia-Naji N, Cauchi S, Balkau B, Marre M, Tichet J, Riveline JP, Hadjadj S, Gallois Y, Czernichow S, Hercberg S, Kaakinen M, Wiesner S, Charpentier G, Lévy-Marchal C, Elliott P, Jarvelin MR, Horber F, Dina C, Pedersen O, Sladek R, Meyre D, Froguel P.

Diabetes. 2009 Nov;58(11):2687-97. doi: 10.2337/db09-0652. Epub 2009 Aug 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk